Search
Upper Respiratory Tract Infection
go.drugbank.com/conditions/DBCOND0035535Drugs: Acetaminophen · Amoxicillin · Bacampicillin · Cefoperazone · Cefpodoxime · Ceftibuten +8 moreSynonyms: Upper Resp Tract InfectionPD-168393
go.drugbank.com/drugs/DB07662ExperimentalPD-168393 is an epidermal growth factor receptor inhibitor.
PD-98059
go.drugbank.com/drugs/DB17042ExperimentalPD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072]
PF-04447943
go.drugbank.com/drugs/DB11953InvestigationalPF-04447943 has been investigated for the treatment of Alzheimer's Disease.
PF-00446687
go.drugbank.com/drugs/DB12517InvestigationalPF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Inotuzumab ozogamicin
go.drugbank.com/drugs/DB05889ApprovedInvestigationalInotuzumab ozogamicin is an antibody-drug conjugate consisting of a humanized IgG4 kappa CD22-targeting monoclonal antibody covalently attached to calicheamicin derivative, N-acetyl-gamma-calicheamicin dimethylhydrazide. The antibody por...
Categories: P-glycoprotein substrates, P-glycoprotein substrates with a Narrow Therapeutic IndexPF-00217830
go.drugbank.com/drugs/DB12998InvestigationalPF-00217830 has been used in trials studying the treatment of Schizophrenia.
Secretin human
go.drugbank.com/drugs/DB09532ApprovedInvestigationalThe main action of secretin is to stimulate the pancreas to secrete pancreatic juice for pH regulation in the small intestines. … The hormone is produced from the enterochromaffin cells in the duodenum in response to the duodenal content with the pH less than 4.5 [L1875].
Helium
go.drugbank.com/drugs/DB09155ApprovedInvestigationalVet approvedHelium is a second most abundant chemical element in the universe with symbol He and atomic number 2. It is a colorless, odorless, tasteless, non-toxic, inert, monatomic gas located at the top of the noble gases on the periodic table. It...
Nurulimab
go.drugbank.com/drugs/DB18946InvestigationalNurulimab is under investigation in clinical trial NCT05732805 (A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-pd-1 Compared to Anti-pd-1 Monotherapy as First-line Treatment in